Does UBLITUXIMAB Cause Muscular weakness? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Muscular weakness have been filed in association with UBLITUXIMAB (BRIUMVI). This represents 1.3% of all adverse event reports for UBLITUXIMAB.
20
Reports of Muscular weakness with UBLITUXIMAB
1.3%
of all UBLITUXIMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Muscular weakness From UBLITUXIMAB?
Of the 20 reports, 1 (5.0%) required hospitalization.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UBLITUXIMAB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does UBLITUXIMAB Cause?
Infusion related reaction (538)
Fatigue (110)
Headache (55)
Inappropriate schedule of product administration (53)
Malaise (49)
Multiple sclerosis relapse (48)
Asthenia (45)
Pain (45)
Illness (43)
Urinary tract infection (42)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which UBLITUXIMAB Alternatives Have Lower Muscular weakness Risk?
UBLITUXIMAB vs UBLITUXIMAB-XIIY
UBLITUXIMAB vs UBROGEPANT
UBLITUXIMAB vs ULIPRISTAL
UBLITUXIMAB vs UMBRALISIB
UBLITUXIMAB vs UMECLIDINIUM